Today: 9 April 2026
British American Tobacco share price in focus before London open after buyback disclosure
23 January 2026
1 min read

British American Tobacco share price in focus before London open after buyback disclosure

London, Jan 23, 2026, 07:59 GMT — Premarket

  • Shares of British American Tobacco ended the session 1.5% higher, closing at 4,313 pence
  • Company repurchased 161,326 shares on Jan. 21 under its buyback programme
  • Investors are eyeing full-year results due on Feb. 12

British American Tobacco shares are set to draw attention on Friday following the announcement of another share buyback program, extending focus on capital returns after a solid previous session. Sharecast

The London-listed tobacco firm has long been a reliable “income” play for investors, boasting a dividend yield north of 5% alongside a buyback scheme that trims its share count. A buyback means the company buys back its own shares, which can shrink the number outstanding and possibly boost earnings per share. Hargreaves Lansdown

UK defensives are catching attention amid headline-driven swoops in global trade policy and shifting interest-rate forecasts that are rattling risk appetite. The FTSE 100 edged higher on Thursday, buoyed by a lift in investor mood, Reuters said. Reuters

BAT bought 161,326 ordinary shares on Jan. 21, paying between 4,214 and 4,295 pence each. The volume-weighted average price — which factors in trade size — came to 4,251.0001 pence. Sharecast

The stock finished at 4,313 pence, gaining 65 pence, or 1.53%, from its prior close, based on data from Hargreaves Lansdown. Hargreaves Lansdown

Investors aren’t just focused on buybacks; they’re also tracking BAT’s pivot to nicotine alternatives amid falling cigarette sales in numerous markets. The Financial Times highlighted this week that products like Vuse vapes and Velo nicotine pouches are gaining traction, becoming central to the stock’s appeal. Financial Times

That said, the risk of a downside remains. Nicotine products face a changing regulatory environment, and stricter rules on vaping or modern oral products could quickly dent volumes and push up compliance and enforcement costs, traders warned. Financial Times

Investors are now waiting on BAT’s upcoming buyback announcements and its full-year 2025 earnings, set for release on Feb. 12. londonstockexchange.com

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Shell share price edges higher in London as Nigeria incentives and Argentina shale sale talk hit the tape
Previous Story

Shell share price edges higher in London as Nigeria incentives and Argentina shale sale talk hit the tape

Adani Enterprises shares slump 5% after Thursday bounce as valuation worries bite again
Next Story

Adani Enterprises shares slump 5% after Thursday bounce as valuation worries bite again

Go toTop